Motesanib
10mM in DMSO
- Product Code: 204361
CAS:
453562-69-1
| Molecular Weight: | 373.46 g./mol | Molecular Formula: | C₂₂H₂₃N₅O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD10567689 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in the treatment of advanced solid tumors, particularly in clinical studies for non-small cell lung cancer and thyroid cancer. It functions as a selective inhibitor of vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptor (PDGFR), and Kit, which are involved in tumor angiogenesis and growth. By blocking these receptors, it helps suppress the formation of new blood vessels that support tumor progression. Investigated in combination with other anticancer agents to enhance therapeutic efficacy.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | £112.02 |
+
-
|
Motesanib
Used in the treatment of advanced solid tumors, particularly in clinical studies for non-small cell lung cancer and thyroid cancer. It functions as a selective inhibitor of vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptor (PDGFR), and Kit, which are involved in tumor angiogenesis and growth. By blocking these receptors, it helps suppress the formation of new blood vessels that support tumor progression. Investigated in combination with other anticancer agents to enhance therapeutic efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :